Sharper & Granite LLC Boosts Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sharper & Granite LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,053 shares of the exchange traded fund’s stock after acquiring an additional 380 shares during the quarter. Sharper & Granite LLC’s holdings in SPDR S&P Biotech ETF were worth $1,085,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in XBI. Bank of New York Mellon Corp raised its stake in shares of SPDR S&P Biotech ETF by 15.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,590 shares of the exchange traded fund’s stock worth $518,000 after purchasing an additional 744 shares during the period. BOKF NA raised its position in SPDR S&P Biotech ETF by 65.5% in the second quarter. BOKF NA now owns 1,390 shares of the exchange traded fund’s stock worth $129,000 after acquiring an additional 550 shares during the period. Envestnet Asset Management Inc. raised its position in SPDR S&P Biotech ETF by 12.5% in the second quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock worth $17,281,000 after acquiring an additional 20,685 shares during the period. Greenwich Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 10.3% in the second quarter. Greenwich Wealth Management LLC now owns 11,505 shares of the exchange traded fund’s stock valued at $1,067,000 after acquiring an additional 1,073 shares during the last quarter. Finally, Bcwm LLC grew its position in shares of SPDR S&P Biotech ETF by 4.2% during the 2nd quarter. Bcwm LLC now owns 42,915 shares of the exchange traded fund’s stock valued at $3,979,000 after acquiring an additional 1,742 shares during the period.

SPDR S&P Biotech ETF Trading Down 0.3 %

Shares of NYSEARCA XBI opened at $89.13 on Tuesday. The firm has a market cap of $6.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock has a fifty day simple moving average of $95.28 and a two-hundred day simple moving average of $97.10. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.